128 related articles for article (PubMed ID: 31816557)
1. Discovery of coumarin-based selective aldehyde dehydrogenase 1A1 inhibitors with glucose metabolism improving activity.
Liang D; Fan Y; Yang Z; Zhang Z; Liu M; Liu L; Jiang C
Eur J Med Chem; 2020 Feb; 187():111923. PubMed ID: 31816557
[TBL] [Abstract][Full Text] [Related]
2. Discovery of benzimidazole derivatives as potent and selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors with glucose consumption improving activity.
Ma Z; Jiang L; Li B; Liang D; Feng Y; Liu L; Jiang C
Bioorg Med Chem; 2021 Sep; 46():116352. PubMed ID: 34403955
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis of 1,3-dimethylpyrimidine-2,4-diones as potent and selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors with glucose consumption improving activity.
Ma Z; Jiang L; Li G; Liang D; Li L; Liu L; Jiang C
Bioorg Chem; 2020 Aug; 101():103971. PubMed ID: 32480173
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of aldehyde dehydrogenases of the 1A subfamily as putative anticancer agents: Kinetic characterization and effect on human cancer cells.
Jiménez R; Pequerul R; Amor A; Lorenzo J; Metwally K; Avilés FX; Parés X; Farrés J
Chem Biol Interact; 2019 Jun; 306():123-130. PubMed ID: 30958995
[TBL] [Abstract][Full Text] [Related]
5. Discovery and development of selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors.
Li B; Yang K; Liang D; Jiang C; Ma Z
Eur J Med Chem; 2021 Jan; 209():112940. PubMed ID: 33328099
[TBL] [Abstract][Full Text] [Related]
6. 3D-QSAR and scaffold hopping based designing of benzo[d]ox-azol-2(3H)-one and 2-oxazolo[4,5-b]pyridin-2(3H)-one derivatives as selective aldehyde dehydrogenase 1A1 inhibitors: Synthesis and biological evaluation.
Verma H; Narendra G; Raju B; Kumar M; Jain SK; Tung GK; Singh PK; Silakari O
Arch Pharm (Weinheim); 2022 Sep; 355(9):e2200108. PubMed ID: 35618489
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the Aldehyde Dehydrogenase 1/2 Family by Psoralen and Coumarin Derivatives.
Buchman CD; Hurley TD
J Med Chem; 2017 Mar; 60(6):2439-2455. PubMed ID: 28219011
[TBL] [Abstract][Full Text] [Related]
8. Discovery of NCT-501, a Potent and Selective Theophylline-Based Inhibitor of Aldehyde Dehydrogenase 1A1 (ALDH1A1).
Yang SM; Yasgar A; Miller B; Lal-Nag M; Brimacombe K; Hu X; Sun H; Wang A; Xu X; Nguyen K; Oppermann U; Ferrer M; Vasiliou V; Simeonov A; Jadhav A; Maloney DJ
J Med Chem; 2015 Aug; 58(15):5967-78. PubMed ID: 26207746
[TBL] [Abstract][Full Text] [Related]
9. Novel Disulfiram Derivatives as ALDH1a1-Selective Inhibitors.
Omran Z
Molecules; 2022 Jan; 27(2):. PubMed ID: 35056791
[TBL] [Abstract][Full Text] [Related]
10. Structural and kinetic features of aldehyde dehydrogenase 1A (ALDH1A) subfamily members, cancer stem cell markers active in retinoic acid biosynthesis.
Pequerul R; Vera J; Giménez-Dejoz J; Crespo I; Coines J; Porté S; Rovira C; Parés X; Farrés J
Arch Biochem Biophys; 2020 Mar; 681():108256. PubMed ID: 31923393
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a series of aromatic lactones as ALDH1/2-directed inhibitors.
Buchman CD; Mahalingan KK; Hurley TD
Chem Biol Interact; 2015 Jun; 234():38-44. PubMed ID: 25641190
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and ex vivo evaluation of a selective inhibitor for retinaldehyde dehydrogenase enzymes.
Harper AR; Le AT; Mather T; Burgett A; Berry W; Summers JA
Bioorg Med Chem; 2018 Dec; 26(22):5766-5779. PubMed ID: 30409702
[TBL] [Abstract][Full Text] [Related]
13. ALDH1A1 in patient-derived bladder cancer spheroids activates retinoic acid signaling leading to TUBB3 overexpression and tumor progression.
Namekawa T; Ikeda K; Horie-Inoue K; Suzuki T; Okamoto K; Ichikawa T; Yano A; Kawakami S; Inoue S
Int J Cancer; 2020 Feb; 146(4):1099-1113. PubMed ID: 31187490
[TBL] [Abstract][Full Text] [Related]
14. Discovery of Orally Bioavailable, Quinoline-Based Aldehyde Dehydrogenase 1A1 (ALDH1A1) Inhibitors with Potent Cellular Activity.
Yang SM; Martinez NJ; Yasgar A; Danchik C; Johansson C; Wang Y; Baljinnyam B; Wang AQ; Xu X; Shah P; Cheff D; Wang XS; Roth J; Lal-Nag M; Dunford JE; Oppermann U; Vasiliou V; Simeonov A; Jadhav A; Maloney DJ
J Med Chem; 2018 Jun; 61(11):4883-4903. PubMed ID: 29767973
[TBL] [Abstract][Full Text] [Related]
15. Characterization of two distinct structural classes of selective aldehyde dehydrogenase 1A1 inhibitors.
Morgan CA; Hurley TD
J Med Chem; 2015 Feb; 58(4):1964-75. PubMed ID: 25634381
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, Biological Evaluation and In Silico Study of Benzyloxybenzaldehyde Derivatives as Selective ALDH1A3 Inhibitors.
Ibrahim AIM; Ikhmais B; Batlle E; AbuHarb WK; Jha V; Jaradat KT; Jiménez R; Pequerul R; Parés X; Farrés J; Pors K
Molecules; 2021 Sep; 26(19):. PubMed ID: 34641313
[TBL] [Abstract][Full Text] [Related]
17. Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy.
Huddle BC; Grimley E; Buchman CD; Chtcherbinine M; Debnath B; Mehta P; Yang K; Morgan CA; Li S; Felton J; Sun D; Mehta G; Neamati N; Buckanovich RJ; Hurley TD; Larsen SD
J Med Chem; 2018 Oct; 61(19):8754-8773. PubMed ID: 30221940
[TBL] [Abstract][Full Text] [Related]
18. UPLC-MS-based metabolomics reveals metabolic dysregulation in ALDH1A1-overexpressed lung adenocarcinoma cells.
Wang Y; Wang CH; Zhang YF; Zhu L; Lei HM; Tang YB
Metabolomics; 2019 Mar; 15(4):52. PubMed ID: 30911937
[TBL] [Abstract][Full Text] [Related]
19. Development of new disulfiram analogues as ALDH1a1-selective inhibitors.
Omran Z
Bioorg Med Chem Lett; 2021 May; 40():127958. PubMed ID: 33744437
[TBL] [Abstract][Full Text] [Related]
20. Development of a high-throughput in vitro assay to identify selective inhibitors for human ALDH1A1.
Morgan CA; Hurley TD
Chem Biol Interact; 2015 Jun; 234():29-37. PubMed ID: 25450233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
